The Current Trends in Research on Panax notoginseng Saponins
Authors:
Open Access
- 24 June 2025
- journal article
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (6)
Abstract
Panax notoginseng (Burk.) F. H. Chen, an esteemed herbal medicine in traditional Chinese medicine (TCM), is notable for its bioactive compounds, particularly Panax notoginseng saponins (PNS), which exhibit a diverse range of pharmacological effects, including anti-inflammatory, antioxidant, anti-apoptotic, and anti-tumor properties, thereby providing significant therapeutic benefits in the context of cardiovascular, nervous system, and immune disorders. The aim of this study was to elucidate the contemporary research trends associated with PNS and to provide a roadmap for future investigative directions. A comprehensive review of the literature on PNS published from 2000 to 2024 was conducted utilizing the Web of Science Core Collection (WoSCC) database, supplemented by analytical tools such as VOSviewer and CiteSpace, which facilitated the identification of several emergent research hotspots, namely “endoplasmic reticulum stress,” “gut microbiota,” “pyroptosis,” “ferroptosis,” and “network pharmacology.” The findings of this groundwork not only highlight the dynamic interest surrounding PNS within the scientific community but also delineate specific thematic avenues that warrant further exploration, thereby fostering future research initiatives aimed at fully elucidating the multifaceted therapeutic potential of PNS in various pathological contexts.Keywords
Funding Information
- National Natural Science Foundation of China (82104593)
- Zhejiang Traditional Chinese Medicine Science and Technology Plan Project (2022ZQ045)
- Zhejiang Traditional Chinese Medicine Science and Technology Plan Project (2025ZL056)
This publication has 54 references indexed in Scilit:
- Panax Notoginseng Saponins Inhibit Apoptosis and Alleviate Renal Ischemia–Reperfusion Injury Through the ROCK2/NF-κB PathwayMolecular Biotechnology, 2025
- Comprehensive pharmacological and experimental study of Ginsenoside Re as a potential therapeutic agent for non-alcoholic fatty liver diseaseBiomedicine & Pharmacotherapy, 2024
- Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injuryBiomedicine & Pharmacotherapy, 2024
- E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseasesBiomedicine & Pharmacotherapy, 2024
- Preparation, characterization, structural analysis and antioxidant activities of phosphorylated polysaccharide from Sanchi (Panax notoginseng) flowerJournal of Food Science and Technology, 2022
- Endoplasmic reticulum stress in liver diseasesHepatology, 2022
- Metabolomics study on the periplocin‐induced cardiotoxicity and the compatibility of periplocin and Panax notoginseng saponins in reducing cardiotoxicity in rats by GC‐MSJournal of Separation Science, 2021
- Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathyCell Stress and Chaperones, 2020
- Effects of superfine grinding on the physicochemical properties and antioxidant activities of Sanchi (Panax notoginseng) flower powdersJournal of Food Science and Technology, 2020
- Anti‐Diabetic Potential of Panax Notoginseng Saponins (PNS): A ReviewPhytotherapy Research, 2013